29 results
S-4
EX-10.54
ONCT
Oncternal Therapeutics Inc
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
with a cytotoxic or cytostatic compound or radionuclide (or any other method of delivering a toxic moiety to a cell using an Antibody). For clarity … or cytostatic compound or radionuclide (or any other method of delivering a toxic moiety to a cell using an Antibody), but excludes aCAR-T Product
S-1
EX-10.17
ONCT
Oncternal Therapeutics Inc
15 Oct 03
IPO registration
12:00am
Product is not safe or is toxic in animal or human
experiments; and/or 2) the process work indicates that GTx's proposed Product is
not feasible, GTx shall
S-4
EX-10.55
ONCT
Oncternal Therapeutics Inc
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
or indirectly with a cytotoxic or cytostatic compound or radionuclide (or any other method of delivering a toxic moiety to a cell using an Antibody … with a cytotoxic or cytostatic compound or radionuclide (or any other method of delivering a toxic moiety to a cell using an Antibody), but excludes
8-K
EX-10.1
ONCT
Oncternal Therapeutics Inc
10 Nov 14
GTx Announces $43.4 Million Private Placement
12:00am
or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (B) has received and is in material compliance … of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes
8-K
EX-1.1
4zy cq3swcq
23 Jun 11
Other Events
12:00am
8-K
EX-1.1
6etqer3fei
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-1.1
3ioosvyl08oq3dsm9n
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
8-K
EX-1.1
j06vfr
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
8-K
EX-1.1
rz0la7 09wm7
14 Dec 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
q109az9qj
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-1.1
deo694b96a8gehz
28 May 21
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.1
4gf mc8ad
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
8-K
EX-1.1
zbf20a9v
27 Oct 10
GTx Announces Pricing of Public Offering of Common Stock
12:00am
8-K
EX-10.1
u8f4k 3k8gkia9vg9
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-1.1
feds7tndpy1v v3
12 Oct 05
GTx Prices Public Offering of Common Stock
12:00am